Virtual Rehabilitation in Parkinson Disease A Dopamine Transporter Imaging Study

被引:5
|
作者
Toldo, Juliana M. P. [1 ]
Arjona, Michelly [1 ]
Campos Neto, Guilherme C. [1 ]
Vitor, Taise [1 ]
Nogueira, Solange Amorim [1 ]
Amaro, Edson, Jr. [1 ]
Saba, Roberta A. [2 ,3 ]
Silva, Sonia M. C. A. [2 ,3 ]
Ferraz, Henrique B. [3 ]
Felicio, Andre C. [1 ]
机构
[1] Hosp Israelita Albert Einstein, Sao Paulo, Brazil
[2] Inst Assistencia Med Servidor Publ Estadual Sao P, Sao Paulo, Brazil
[3] Univ Fed Sao Paulo, Sao Paulo, Brazil
基金
巴西圣保罗研究基金会;
关键词
Parkinson Disease; Virtual Rehabilitation; Dopamine Transporter; SPECT; TC-99M-TRODAT-1; SPECT; STRIATAL DOPAMINE; BALANCE; MOTOR; EXERCISE; ATTENTION; DEFICITS; REALITY; GAIT;
D O I
10.1097/PHM.0000000000001574
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective The aim of the study was to verify the effect of a virtual rehabilitation protocol for patients with Parkinson disease, primarily assessing striatal dopamine transporters and secondarily motor symptoms and quality of life. Design Nineteen patients with Parkinson disease underwent an 8-wk virtual rehabilitation protocol using XBOX 360S. Evaluation of dopamine transporters was performed by single-photon emission computed tomography using TRODAT-1 as the radioligand. Participants were clinically assessed using the Unified Parkinson Disease Rating Scale to quantify motor symptoms. Moreover, the Parkinson Disease Questionnaire and Short-Form Health Status Survey were used to assess quality of life and the Berg Balance Scale to assess balance. Results Regarding our primary outcome, dopamine transporter was significantly increased in the putamen contralateral to the clinically most affected body side (P = 0.034) considering preintervention and postintervention measurements. Furthermore, we observed significant improvement in Unified Parkinson Disease Rating Scale (10-point reduction, P = 0.001), Parkinson Disease Questionnaire (11.3-point reduction, P = 0.001), Short-Form Health Status Survey ("Functional capacity," P = 0.001; "Pain," P = 0.006; and "Mental Health" domains, P < 0.001), and Berg Balance Scale (5-point increase, P = 0.015). Conclusions In our group of Parkinson disease patients, this virtual rehabilitation protocol enabled a dopamine transporter increase in the region of the putamen contralateral to the clinically most affected body side. Moreover, motor signs and quality of life were significantly improved.
引用
收藏
页码:359 / 366
页数:8
相关论文
共 50 条
  • [41] Dopamine transporter gene polymorphism, SPECT imaging, and levodopa response in patients with Parkinson disease
    Contin, M
    Martinelli, P
    Mochi, M
    Albani, F
    Riva, R
    Scaglione, C
    Dondi, M
    Fanti, S
    Pettinato, C
    Baruzzi, A
    CLINICAL NEUROPHARMACOLOGY, 2004, 27 (03) : 111 - 115
  • [42] Dopamine transporter relation to dopamine turnover in Parkinson's disease:: A positron emission tomography study
    Sossi, Vesna
    de la Fuente-Fernandez, Raul
    Schulzer, Mihael
    Troiano, Andre R.
    Ruth, Thomas J.
    Stoessl, A. Jon
    ANNALS OF NEUROLOGY, 2007, 62 (05) : 468 - 474
  • [43] Striatal Dopamine Loss in Early Parkinson's Disease: Systematic Review and Novel Analysis of Dopamine Transporter Imaging
    Heng, Nicholas
    Malek, Naveed
    Lawton, Michael A.
    Nodehi, Anahita
    Pitz, Vanessa
    Grosset, Katherine A.
    Ben-Shlomo, Yoav
    Grosset, Donald G.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2023, 10 (04): : 539 - 546
  • [44] Dopamine PET Imaging and Parkinson Disease
    Peng, Shichun
    Doudet, Doris J.
    Dhawan, Vijay
    Ma, Yilong
    PET CLINICS, 2013, 8 (04) : 469 - +
  • [45] Dopamine Transporter (DAT) Imaging and Motor Cortex Stimulation in Parkinson's Disease: a Follow-up SPET Study
    Di Giuda, D.
    Calcagni, M. L.
    Totaro, M.
    Bentivoglio, A. R.
    Bruno, I.
    Cioni, B.
    Castaldi, P.
    Baldari, G.
    Mattioli, D.
    Frusciante, V.
    Giordano, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 : S307 - S307
  • [46] Dopamine transporter imaging under high-dose transdermal nicotine therapy in Parkinson's disease: an observational study
    Itti, Emmanuel
    Villafan, Gabriel
    Malek, Zoulikha
    Brugieres, Pierre
    Capacchione, Daniela
    Itti, Laurent
    Maison, Patrick
    Cesaro, Pierre
    Meignan, Michel
    NUCLEAR MEDICINE COMMUNICATIONS, 2009, 30 (07) : 513 - 518
  • [47] Virtual reality for rehabilitation in Parkinson's disease
    Dockx, Kim
    Bekkers, Esther M. J.
    Van den Bergh, Veerle
    Ginis, Pieter
    Rochester, Lynn
    Hausdorff, Jeffrey M.
    Mirelman, Anat
    Nieuwboer, Alice
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (12):
  • [48] Evaluating dopamine transporter imaging as an enrichment biomarker in a phase 2 Parkinson’s disease trial
    R. Matthew Hutchison
    Karleyton C. Evans
    Tara Fox
    Minhua Yang
    Jerome Barakos
    Barry J. Bedell
    Jesse M. Cedarbaum
    Miroslaw Brys
    Andrew Siderowf
    Anthony E. Lang
    BMC Neurology, 21
  • [49] Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease
    Ponsen, Mirthe M.
    Stoffers, Diederick
    Wolters, Erik Ch
    Booij, Jan
    Berendse, Henk W.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2010, 81 (04): : 396 - 399
  • [50] Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression
    Marek, K
    Seibyl, J
    Shoulson, I
    Holloway, R
    Kieburtz, K
    McDermott, M
    Kamp, C
    Shinaman, A
    Fahn, S
    Lang, A
    Weiner, W
    Welsh, M
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (13): : 1653 - 1661